Ibuprofen/Pseudoephedrine Hydrochloride

布洛芬/盐酸伪麻黄碱

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIbuprofen/Pseudoephedrine Hydrochloride
Drug Alias NamePseudoephedrine Hydrochloride and Ibuprofen盐酸伪麻黄碱/布洛芬Pseudoephedrine Hydrochloride/IbuprofenIbuprofen and Pseudoephedrine HydrochlorideAdvil Cold And Sinus
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsAlpha adrenergic receptor agonists
TargetsAlpha adrenergic receptorCyclooxygenases
Therapy Area/IndicationsNasal ObstructionCommon Cold
Global Approved IndicationsNasal ObstructionCommon Cold
Approved Indications in ChinaNasal ObstructionCommon Cold
Original Approved Country/TerritoryUnited States
Original Approved Date1989/09/19
Country/TerritoryUnited StatesMainland China
CombinationsYes IbuprofenPseudoephedrine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesHaleon PLCHebei Jiheng (Group) Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNasal ObstructionCommon Cold
Inactive IndicationsN/A

Other Information

ATC CodeR05X
Related LinksN/A